Endocrine Society

Experts at ENDO 2026, the Endocrine Society's annual meeting, discussed expanding hypercortisolism treatment beyond Cushing syndrome to address broader cardiometabolic health implications.

The Federal Trade Commission and four states sued the World Professional Association for Transgender Health (WPATH) over alleged deceptive claims about gender-affirming care for minors. WPATH responded by asserting its guidelines prioritize individualized care and cited a prior court ruling blocking an FTC investigation into the organization.

The Federal Trade Commission and four states sued the World Professional Association for Transgender Health (WPATH) over alleged deceptive claims about gender-affirming care for minors. WPATH stated its guidelines prioritize individualized care and criticized the FTC for targeting medical organizations. A federal court previously blocked an FTC investigation into WPATH, citing First Amendment concerns.

The Federal Trade Commission and four states sued the World Professional Association for Transgender Health (WPATH), alleging deceptive claims about gender-affirming care for minors and profiting from them. WPATH claims its guidelines are individualized and previously blocked an FTC investigation, which a court supported. The FTC is also investigating the American Academy of Pediatrics and the Endocrine Society over similar allegations.

A new study suggests that adults taking GLP-1 medications like Ozempic or Wegovy for weight loss are significantly reducing their physical activity, with decreases in daily steps and moderate-to-vigorous exercise. Researchers emphasize that exercise remains essential for preserving strength and long-term health when using these drugs, despite the observed decline in activity.

The Endocrine Society released its first clinical practice guideline on central precocious puberty (CPP), advising against a uniform approach to testing and treatment for affected children.